Clinical Trial Update: 5-Alpha Reductase and Anabolic Effects of Testosterone [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating the anabolic effects of testosterone via 5-alpha reductase pathways in men with hypogonadism and muscle atrophy, completed with results…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Benign Prostatic Hypertrophy
• Male Hypogonadism
• Muscle Atrophy
• Sarcopenia

Drugs mentioned

• TESTOSTERONE (testosterone)

Snippet

Sponsor: VA Office of Research and Development | Conditions: Male Hypogonadism, Muscle Atrophy | Phase 2 | Status: COMPLETED | Results posted: 2014-07-31